Cargando…
Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease
PURPOSE: In order to maximise the utility of [(11)C]-PBR28 for use in longitudinal studies and clinical trials in Alzheimer’s disease (AD), there is a need to develop non-invasive metrics of tracer binding that do not require arterial cannulation. Recent work has suggested that standardised uptake v...
Autores principales: | Nair, Akshay, Veronese, Mattia, Xu, Xiaohui, Curtis, Charles, Turkheimer, Federico, Howard, Robert, Reeves, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039146/ https://www.ncbi.nlm.nih.gov/pubmed/27678494 http://dx.doi.org/10.1186/s13550-016-0226-3 |
Ejemplares similares
-
Erratum to: Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease
por: Nair, Akshay, et al.
Publicado: (2017) -
Parametric mapping using spectral analysis for (11)C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects
por: Fan, Zhen, et al.
Publicado: (2018) -
Quantification of [(11)C]PBR28 data after systemic lipopolysaccharide challenge
por: Woodcock, Eric A., et al.
Publicado: (2020) -
Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data
por: Matheson, Granville J., et al.
Publicado: (2017) -
Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study
por: Marques, Tiago Reis, et al.
Publicado: (2021)